Supriya Lifescience, a Mumbai-based company specializing in active pharmaceutical ingredients (API), has announced its recent collaboration with Plasma Nutrition, a United States-based company known for innovative consumer products located at Delaware. The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimized Protein (ioProtein) in India.
The primary purpose of this collaboration is to bring the optimized protein into the Indian market. ioProtein is a patented process (patent pending in the US) This protein powder is designed for use as protein supplements and is highly bioavailable. It means higher amounts of proteins are absorbed quickly by the body, providing consumers with a more effective and efficient protein supplement.
During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India. This marks the introduction of a new category of protein powders in the Indian market, and it is relatively healthier compared to other popular protein powders available through various Gyms, general stores, and digital marketing channels.
“We are thrilled to be the exclusive partner of Plasma Nutrition, Inc in introducing the innovative ioProtein to the Indian market,” said Dr Saloni Wagh, Executive director at Supriya Lifescience. “This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionize the nutrition industry and become the preferred choice for health-conscious individuals.”
“We are excited to collaborate with Supriya Lifescience Ltd and bring our patented ioProtein technology to India,” said Chris Flynn-Rozanski, co-founder & CEO at Plasma Nutrition, Inc. “India’s rapidly growing demand for protein supplements presents an excellent opportunity for us to introduce this highly bioavailable protein powder, which has already been well-received in other markets. We believe this partnership will create a new standard for protein supplementation in India.”
GCV Life led by Shailesh Gadre played a pivotal role as an exclusive advisor in facilitating this landmark transaction. GCV Life, known for its expertise in investment banking & innovation licensing, will spearhead the marketing of the ‘Ingredient Optimized’ products as per the arrangement among the three companies.
Established in 1987, Supriya Lifescience is a global manufacturer of active pharmaceutical ingredients. Its facility is located in Khed in Ratnagiri district of Maharashtra and headquartered in Mumbai, India.
